Consumers, doctors and other advocates agree pharmacy benefit managers (PBMs) wield too much power and influence over patients’ access to medicines and their prices.

CVS Caremark, and Express Scripts. The lawsuit could be filed within weeks – potentially before the end of the month – and could end up being a signature action by FTC chair Lina Khan ...

An examination of recent litigation under the Employee Retirement Income Security Act of 1974 (ERISA) challenging allegedly ...

Stephen Diroux with Wurlitzer Family Pharmacy says it’s a tragedy to see Rite Aid leave New York, however, this outlines a ...

Last year, the Federal Trade Commission (FTC) caused consternation ... the big three players in the sector – CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx.

CVS owns roughly 10,000 stores, as well as owning health insurer Aetna. The combined company also owns a PBM, Caremark. Meanwhile ... owns a brick-and-mortar or online pharmacy. The FTC study found ...

CVS Caremark has removed several diabetes drugs favor of newer ... and they are less likely to recommend their PBM. The FTC said it is focusing on insulin as the “poster child” of a broken system, ...

CVS Caremark to list Wegovy as preferred GLP-1 drug on top formularies starting July 1, 2025. Novo Nordisk plans continued collaboration with CVS to widen Wegovy access. Feel unsure about the ...

"Now that there's adequate supply of both of these GLP-1s, CVS Caremark was able to negotiate Wegovy against Zepbound to determine which manufacturer of these clinically similar products could ...

Eli Lilly and Company's stock fell over 11% after CVS Caremark excluded Lilly’s obesity drug Zepbound from its standard commercial formularies starting July 1, 2025. The market overreacted to ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template formularies, Novo said Thursday. CVS Caremark, which forms the ...

CVS’ pharmacy benefit manager Caremark also reached an agreement with Danish drugmaker Novo Nordisk to give its weight loss drug Wegovy preferred access on Caremark’s standard formulary ...